COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 1686: Articles 16851-16860  | Next

Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalization rates in February 2021, Rio Grande do Sul, Southern Brazil
Martins, A. F., Zavascki, A. P., Wink, P. L., Volpato, F. C. Z., Monteiro, F. L., Rosset, C., de-Paris, F., Ramos, A. K., Barth, A. L.
10.1101/2021.03.09.21253204 — Posted: 2021-03-12
A Recovery Algorithm and Pooling Designs for One-Stage Noisy Group Testing under the Probabilistic Framework
Liu, Y., Kadyan, S., Pe'er, I.
10.1101/2021.03.09.21253193 — Posted: 2021-03-12
An In-House ELISA for SARS-CoV-2 RBD uncovers elevatedimmune response at higher altitudes
Tomas Grau, R., Ploper, D., Avila, C. L., Vera Pingitore, E., Maldonado, C., Chaves, S., Socias, S. B., Stagnetto, A., Navarro, S., Chahla, R., Aguilar, M., Llapur, C., Aznar, P., Alcorta, M., Costas, D., Flores, I., Apfelbaum, G., Heinze, D., Mostoslavsky, R., Mostoslavsky, G., Perdigon, G., Cazorla, S., Chehin, R.
10.1101/2021.03.10.21252711 — Posted: 2021-03-12
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers
Padoan, A., Bonfante, F., Cosma, C., Di Chiara, C., Sciacovelli, L., Pagliari, M., Bortolami, A., Costenaro, P., Musso, G., Basso, D., Plebani, M.
10.1101/2021.03.10.21253260 — Posted: 2021-03-12
Global association of obesity and COVID-19 death rates
Adams, M. L.
10.1101/2021.03.09.21253222 — Posted: 2021-03-12
Higher viral load drives infrequent SARS-CoV-2 transmission between asymptomatic residence hall roommates
Bjorkman, K. K., Saldi, T. K., Lasda, E., Conners Bauer, L., Kovarik, J., Gonzales, P. K., Fink, M. R., Tat, K. L., Hager, C. R., Davis, J. C., Ozeroff, C. D., Brisson, G. R., Larremore, D. B., Leinwand, L. A., McQueen, M. B., Parker, R.
10.1101/2021.03.09.21253147 — Posted: 2021-03-12 Discussion: Offsite
The Value of Rapid Antigen Tests to Identify Carriers of Viable SARS-CoV-2.
Shidlovskaya, E. V., Kuznetsova, N. A., Divisenko, E. V., Nikiforova, M. A., Siniavin, A. E., Ogarkova, D. A., Shagaev, A. V., Semashko, M. A., Tkachuk, A. P., Burgasova, O. A., Gushchin, V. A.
10.1101/2021.03.10.21252667 — Posted: 2021-03-12
Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland
Hobbie, S. N.
10.1101/2021.03.10.21253079 — Posted: 2021-03-12
Quantified Flu: an individual-centered approach to gaining sickness-related insights from wearable data
Greshake Tzovaras, B., Senabre Hidalgo, E., Alexiou, K., Baldy, L., Morane, B., Bussod, I., Fribourg, M., Wac, K., Wolf, G., Ball, M.
10.1101/2021.03.10.21252242 — Posted: 2021-03-12
Maximisation of open hospital capacity under shortage of SARS-CoV-2 vaccines
Bosbach, W. A., Heinrich, M., Kolisch, R., Heiss, C.
10.1101/2021.03.08.21253150 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).